One-year data from global atrial fibrillation (AF) registry show antithrombotic agents not optimally used to prevent stroke

One-year outcomes data from the first cohort of the Global Anticoagulant Registry in the FIELD (GARFIELD), an innovative, independent academic research initiative, provide insights into the elevated stroke risk among subpopulations of patients with atrial fibrillation (AF). The findings, from eight abstracts presented this week at the ESC Congress 2013, collectively show that anticoagulant therapy - which is known to significantly lower stroke risk in AF patients - is consistently under-utilised among those at-risk AF patients...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Stroke Source Type: news